828 related articles for article (PubMed ID: 29314090)
1. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
2. Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
J Pharm Biomed Anal; 2017 Sep; 143():305-310. PubMed ID: 28645021
[TBL] [Abstract][Full Text] [Related]
3. Rapid bioanalytical LC-MS/MS method for the simultaneous determination of sofosbuvir and velpatasvir in human plasma-application to a pharmacokinetic study in Egyptian volunteers.
Elkady EF; Aboelwafa AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():116-124. PubMed ID: 30384188
[TBL] [Abstract][Full Text] [Related]
4. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.
Ferrari D; Bagaglio S; Raso M; Galli L; Premaschi S; Messina E; Morsica G; Locatelli M; Uberti-Foppa C; Hasson H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():1-7. PubMed ID: 31055190
[TBL] [Abstract][Full Text] [Related]
5. UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
Notari S; Tempestilli M; Fabbri G; Libertone R; Antinori A; Ammassari A; Agrati C
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():183-190. PubMed ID: 29276983
[TBL] [Abstract][Full Text] [Related]
6. Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.
Rezk MR; Basalious EB; Amin ME
Biomed Chromatogr; 2016 Sep; 30(9):1354-62. PubMed ID: 26821881
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of sensitive and rapid UPLC-MS/MS method for quantitative determination of daclatasvir in human plasma: Application to a bioequivalence study.
Rezk MR; Bendas ER; Basalious EB; Karim IA
J Pharm Biomed Anal; 2016 Sep; 128():61-66. PubMed ID: 27232152
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of liquid chromatography-electrospray-tandem mass spectrometry method for determination of flibanserin in human plasma: Application to pharmacokinetic study on healthy female volunteers.
Sultan MA; El-Eryan RT; Attia AK; Eissa MJ
Biomed Chromatogr; 2019 Aug; 33(8):e4545. PubMed ID: 30937940
[TBL] [Abstract][Full Text] [Related]
10. Investigation of anti-Hepatitis C virus, sofosbuvir and daclatasvir, in pure form, human plasma and human urine using micellar monolithic HPLC-UV method and application to pharmacokinetic study.
Zidan DW; Hassan WS; Elmasry MS; Shalaby AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():73-81. PubMed ID: 29660665
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC-MS/MS technique: Application to a bioequivalence study.
Miraghaei S; Mohammadi B; Babaei A; Keshavarz S; Bahrami G
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():118-122. PubMed ID: 28858753
[TBL] [Abstract][Full Text] [Related]
12. Quick and Sensitive UPLC-ESI-MS/MS Method for Simultaneous Estimation of Sofosbuvir and Its Metabolite in Human Plasma.
Semreen MH; Alniss HY; Mousa MK; Aboul-Enein HY
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987096
[TBL] [Abstract][Full Text] [Related]
13. Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS method: Application to a bioequivalence study.
Rezk MR; Basalious EB; Badr KA
Biomed Chromatogr; 2018 Nov; 32(11):e4347. PubMed ID: 30047564
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits.
Atia NN; El-Shaboury SR; El-Gizawy SM; Abo-Zeid MN
J Pharm Biomed Anal; 2018 Sep; 158():88-93. PubMed ID: 29864695
[TBL] [Abstract][Full Text] [Related]
15. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
Rezk MR; Basalious EB; Karim IA
J Pharm Biomed Anal; 2015 Oct; 114():97-104. PubMed ID: 26037157
[TBL] [Abstract][Full Text] [Related]
16. A Rapid and Optimized LC-MS/MS Method for the Simultaneous Extraction and Determination of Sofosbuvir and Ledipasvir in Human Plasma.
Elkady EF; Aboelwafa AA
J AOAC Int; 2016 Sep; 99(5):1252-9. PubMed ID: 27480956
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
[TBL] [Abstract][Full Text] [Related]
18. Validated RP-HPLC Method for Simultaneous Determination of Ribavirin, Sofosbuvir and Daclatasvir in Human Plasma: A Treatment Protocol Administered to HCV Patients in Egypt.
Youssef AA; Magdy N; Hussein LA; El-Kosasy AM
J Chromatogr Sci; 2019 Aug; 57(7):636-643. PubMed ID: 31063182
[TBL] [Abstract][Full Text] [Related]
19. Quantification of sofosbuvir and ledipasvir in human plasma by UPLC-MS/MS method: Application to fasting and fed bioequivalence studies.
Rezk MR; Bendas ER; Basalious EB; Karim IA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():63-70. PubMed ID: 27322631
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Pan C; Chen Y; Chen W; Zhou G; Jin L; Zheng Y; Lin W; Pan Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():255-259. PubMed ID: 26684720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
